MSK and Illumina Launch Comprehensive Circulating Tumor DNA Program

News   Sep 17, 2015

 
MSK and Illumina Launch Comprehensive Circulating Tumor DNA Program
 
 
 

RELATED ARTICLES

Targeting Epigenetic Proteins to Prevent Breast Cancer

News

Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.

READ MORE

Gene Editing Technology May Improve Accuracy of Predicting Heart Disease Risk

News

Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.

READ MORE

Targeting the Engine Room of the Cancer Cell

News

Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy